A court has found Ariosa Diagnostics infringed a patent held by Sequenom for a noninvasive prenatal genetic test, and ruled one claim of the patent invalid for lack of fair basis.
Dairy supplier Murray Goulburn has agreed to pay $42 million to settle one of two shareholder class actions over a 2016 profit forecast revision that sent the co-op’s unit price falling more than 40 per cent in five days.
A firm owned by solicitor Mark Elliot has launched an appeal challenging costs orders made against it in a stayed class action against winemaker Treasury Wine Estates.
Rival law firms Phi Finney McDonald and Maurice Blackburn have offered to consolidate their competing shareholder class actions against BHP after prompting by the Full Federal Court, which said Friday it approved of the plan.
One of the top Australian executives of Herbert Smith Freehills has advocated for a UK-style quartile pay transparency system Down Under, calling on law firms to air their “dirty laundry” when it comes to the gender pay gap.
The law firm running a cartel class action alleging manipulation of foreign exchange rates by five global investment banks is teaming up with the same lead applicant that represented group members in the price-fixing case against major international airlines.
The potential source of alleged “industrial espionage” in Motorola’s case against Hytera over the intellectual property for its digital radio mobile devices has been revealed as a mystery woman with two laptops that contained a “very large number of Motorola documents”, a court has heard.
The Australian Competition and Consumer Commission has told the court there’s “at least a real chance” TPG will resume plans to roll out a 5G mobile network after its earlier plans were thwarted by the government’s ban on the use Huawei technology, as the regulator defends its decision to block the proposed $15 billion tie-up between TPG and Vodafone.
Israeli drug giant Teva and German drug maker Boehringer Ingelheim have settled their dispute over a patented capsule used to deliver the medicine in Boehringer’s top-selling inhaler Spiriva.
ANZ Bank will not pay a cent to franchisees in its settlement of two class actions that allege the bank breached its responsible lending obligations and engaged in unconscionable conduct by giving loans to purchasers of 7-Eleven franchises.